Due to continued research and experience, USEF Drugs and Medication Guidelines regarding detomidine (brand name: Dormosedan) have been updated, which will help veterinarians in their role as guardians of the horse to assist their clients in responsible management of their horses when competing under USEF rules and regulations.
Posted on Jun 5, 2019
USEF Announces Positive Tests of Cannabinoids (CBD) Will Result in GR4 Violations as of September 1, 2019
Tasked with protecting the welfare of equine athletes and ensuring the balance of competition, the US Equestrian Federation (USEF) Equine Drugs and Medications Program consistently monitors new products and product claims. From time to time, new products appear on the equine supplement market claiming to enhance a horse’s performance. Over the last several years, cannabinoids have gained increased attention and have become nearly mainstream.
Posted on May 16, 2019